# Molecular Intelligence X

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/molecular-intelligence-x

- Industry: Biotechnology
- Headquarters: Hangzhou, China
- Latest round: Angel (Oct 20, 2022)
- Investors on record: 2

## About

Based in Hangzhou, China, and founded in 2021, Molecular Intelligence X, as known as MIX,  operates as a biotechnology service provider that focuses on AI gene editing and gene therapy. The founder, Pengkai Pan, worked at Zhejiang University, and the core team members graduated from Zhejiang University and Massachusetts Institute of Technology. Zhijiang Lab and the company jointly established the AI Life Science Research Center. MIX was granted patents related to CRISPR/Cas9.

Molecular Intelligence X combines CRISPR and artificial intelligence to focus on intelligent nucleic acid detection research and smart cell drug development. MIX has built a CRISPR complex intelligent design cloud platform based on Zhijiang Lab's Tianshu AI open source platform and cloud platform. The company has also built an intelligent nucleic acid detection platform and an intelligent gene editing immune cell platform, and developed intelligent nucleic acid detection products and intelligent cellular drugs.

## Funding rounds

- Angel, Oct 20, 2022 — Goldport Capital, Zhijiang Lab

## Investors

- Goldport Capital (https://capitalatlas.ai/funds/goldport-capital) — Angel
- Zhijiang Lab — Angel